The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The rate of tumor growth, g, as a biomarker for overall survival (OS) in prostate cancer (PC) in clinical trials as well as in real-world data from the Veterans Administration Medical Centers (VAMCs).
 
Harshraj Leuva
No Relationships to Disclose
 
Mengxi Zhou
No Relationships to Disclose
 
Julia Wilkerson
No Relationships to Disclose
 
Keith Sigel
No Relationships to Disclose
 
Ta-Chueh Hsu
No Relationships to Disclose
 
David Henry Aggen
Consulting or Advisory Role - Boehringer Ingelheim
Patents, Royalties, Other Intellectual Property - University of Illinois - Urbana Champaign
 
Erik Langhoff
No Relationships to Disclose
 
Yeun-Hee Anna Park
No Relationships to Disclose
 
Susan Elaine Bates
Research Funding - Agios
Patents, Royalties, Other Intellectual Property - Patent: Deacetylase Inhibitor Therapy (Inst); Patent: Depsipeptide for Therapy of Kidney Cancer (Inst)
 
Antonio Tito Fojo
Consulting or Advisory Role - Cerulean Pharma
Patents, Royalties, Other Intellectual Property - Very small amount of royalties from the federal government from a long-standing agreement on taxol. This has now ended.